Long-term outcome and toxicity of hypofractionated stereotactic body radiotherapy as a boost treatment for head and neck cancer: the importance of boost volume assessment
Measurement of Beam Data for Small Field Radiosurgical Fields: Comparison of CyberKnife Multi-sites in Korea
장지선, 강영남, 신헌주, 서재혁, 김문찬, 이동준, 권수일
PROGRESS IN NUCLEAR SCIENCE AND TECHNOLOGY, 201102
36
STEREOTACTIC BODY RADIOTHERAPY FOR PATIENTS WITH UNRESECTABLE PRIMARY HEPATOCELLULAR CARCINOMA: DOSE-VOLUMETRIC PARAMETERS PREDICTING THE HEPATIC COMPLICATION
손석현, 최병옥, 유미령, 강영남, 장지선, 배시현, 윤승규, 최일봉, 강기문, 장홍석
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 201011
37
Helical tomotherapy with concurrent capecitabine for the treatment of inoperable pancreatic cancer
지정선, 한치화, 장정원, 이보인, 김병욱, 최황, 김지윤, 강영남, 계철승, 최일봉
RADIATION ONCOLOGY, 201006
38
Stereotactic body radiation therapy with or without transarterial chemoembolization for patients with primary hepatocellular carcinoma: preliminary analysis
장지선, 최일봉, 최병옥, 윤승규, 장홍석, 강영남, 배시현, 채규영, 강기문
BMC CANCER, 200811
39
Fractionated Stereotactic Radiotherapy in Patients with Primary
강영남
Japanese Journal of Clinical Oncology - 직접입력, 200603